ANDA Cases Will Hit Decade Low, Suggests H1 2021 Data

Managing Intellectual Property analyzed ANDA litigation filings for the first half of 2021, reporting a 47% decline compared to the first half of 2020. Finnegan partner Laura Masurovsky believes the drop is likely a result of the pandemic and its impact on the pharmaceutical industry, as well as the typical cycle of patents that cover pharmaceutical treatments available for generic challenge. She said, “We’re seeing a lifecycle of patents playing out in general. This is creating a slowdown in ANDA filings by limiting the availability of products that can be challenged because of their patent expiration dates.”

According to the data, Finnegan was the second most active ANDA firm for patent owners in the first half of 2021. Additionally, attorneys James Monroe, Lauren Dowty, Meredith Boerschlein, Charles Collins-Chase, Bryan Diner, Justin Hasford, Ryan McDonnell, and Jennifer Roscetti were named top attorneys for ANDA patent owners in the first half of 2021.

Read “ANDA Cases Will Hit Decade Low, Suggests H1 2021 Data”